IMNP master presentation Jul22Rev

Corporate Presentation

 


Immune Pharmaceuticals 

Immune Pharmaceuticals to Advance its Immuno-Dermatology and Inflammatory
Bowel Disease Product Candidates

Science And Medicine

Science And Medicine

IMMUNE is focused on developing the next generation of monoclonal antibodies to
address significant unmet medical needs in
the treatment of cancer and inflammatory diseases. Our goal is to improve patients’ lives through targeted medicine.
Read More

Special Event

Special Event

Watch the CEO Signature Series interview with Dr. Daniel Teper, Founder and Chief Executive Officer of IMMUNE Pharmaceuticals
Watch Official Video